Celldex Therapeutics Prepares for Key Investor Engagements
Celldex Therapeutics, Inc. (NASDAQ:CLDX) is excited to announce its participation in significant investor conferences that are on the horizon. These events represent an excellent opportunity for the company to connect with investors and share advancements in their innovative therapeutic solutions.
Fireside Chats to Highlight Advances
Management will engage in fireside chats, where they will outline the latest developments in their clinical research and therapeutic portfolio:
Upcoming Conference Dates
Celldex will be present at the TD Cowen 45th Annual Health Care Conference, scheduled for 1:50 p.m. ET on an upcoming Tuesday. Following that, they are set to participate in the Leerink Partners Global Healthcare Conference, which will take place at 1:00 p.m. ET the following week.
Live Presentation Access
Investors can look forward to live webcasts of the discussions. These will be accessible through the Events & Presentations page on the Celldex Therapeutics website. Those who are unable to attend the live sessions need not worry; replays will be available for a period of 90 days post-event, allowing ample time to catch up on critical insights.
About Celldex Therapeutics, Inc.
Celldex is at the forefront of biotechnology, particularly recognized for its pioneering work in the realm of mast cell biology. The company is dedicated to developing transformative therapeutics for patients suffering from a range of challenging health conditions. Their portfolio boasts antibody-based therapeutics designed to activate the human immune system and address critical pathways for treating severe inflammatory, allergic, autoimmune, and other life-altering diseases.
Commitment to Innovation
The ongoing dedication exhibited by Celldex Therapeutics towards innovation and patient care sets them apart in the biotechnology industry. Their research efforts aim to yield significant improvements in patient outcomes, ensuring that they remain an influential player in health care.
Company Contact Information
For any inquiries, interested parties can reach out to:
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
Frequently Asked Questions
What is Celldex Therapeutics known for?
Celldex Therapeutics is known for its innovative approaches in biotechnology, particularly in developing therapeutics related to mast cell biology.
When will Celldex participate in the investor conferences?
Celldex will participate in the TD Cowen 45th Annual Health Care Conference and the Leerink Partners Global Healthcare Conference on upcoming specified dates.
How can I access the live webcasts?
The live webcasts will be available on the Events & Presentations page of the Celldex website, allowing investors to tune in remotely.
Will there be replays available for the presentations?
Yes, replays of the presentations will be made available for 90 days after the live events, ensuring that all interested individuals can catch up on what was discussed.
Who can I contact for more information about Celldex?
Contact Sarah Cavanaugh or Patrick Till through the provided phone numbers or email addresses for any inquiries regarding Celldex Therapeutics.